A Study in Patients With Mixed Dyslipidemia
Clinical trial NCT06497127 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06497127
- Sponsor
- Shanghai Argo Biopharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-28
- Primary completion
- 2026-06-30
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.